Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03219567 · ClinicalTrials.gov registry record
Whole Eye Optical Coherence Tomography (OCT) to Improve Refractive Surgery and Eye Care
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 82
- Enrollment target
NCT03219567: Clinical Trial study, sponsored by Duke University.
NCT03219567 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 82 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03219567 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 82 participants
- Enrollment target
Study Summary
The overall objective is to develop the hardware systems and software algorithms necessary to make accurate measurements of the whole eye with optical coherence tomography (OCT). The research procedure that each subject will undergo is imaging with the OCT system. Three populations will be included: 1. Normals to ensure the imaging range of the system, 2. Patients with previous LASIK who will be undergoing cataract surgery, and 3. Patients with a history of cataract surgery or high myopia. The third group will also undergo MRI imaging for comparison. There are no known risks to the subject from imaging with optical coherence tomography beyond what is normal for standard ocular photographic procedures. Light exposure is below ANSI limits. In groups 2 and 3, clinical parameters drawn from the OCT images will be compared to standard of care imaging.
Primary Outcome
The radius of curvature of the posterior eye will be measured via surface fitting of the posterior eye data from OCT and MRI. Data reported reflects the Rc of the posterior eye measured by OCT minus the value obtained by MRI measurement.
Interventions
- DEVICE Magnetic resonance imaging (MRI)
- DEVICE Optical Coherence Tomography (OCT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2014-10-09 |
| Est. Completion | 2019-11-21 |
Why NCT03219567 stopped before completion
NCT03219567 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Magnetic resonance imaging (MRI) is the first listed.
NCT03219567 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03219567 about?
NCT03219567 is a clinical study titled "Whole Eye Optical Coherence Tomography (OCT) to Improve Refractive Surgery and Eye Care". The overall objective is to develop the hardware systems and software algorithms necessary to make accurate measurements of the whole eye with optical coherence tomography (OCT). The research procedure that each subject will undergo is imaging with the OCT system. Three populations will be included...
What is the current status of trial NCT03219567?
This trial is currently terminated. The enrollment target is 82 participants. The study started on 2014-10-09. Estimated completion is 2019-11-21.
What interventions are being tested in trial NCT03219567?
The interventions under investigation include: Magnetic resonance imaging (MRI) (DEVICE), Optical Coherence Tomography (OCT) (DEVICE).
Who is sponsoring clinical trial NCT03219567?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI